Chengdu

The trials here

What the trial at this site is about, from its registry record.

Conditions

• IgA nephropathy

Running trials

• Enrolling by invitation

  Trial of Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN)

  NCT05248659· Phase 2/3· Otsuka Pharmaceutical Development & Commercialization, Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• IgA nephropathy1 recruiting